Naomy Bernstein

517 total citations
7 papers, 232 citations indexed

About

Naomy Bernstein is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Naomy Bernstein has authored 7 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Naomy Bernstein's work include Epigenetics and DNA Methylation (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Naomy Bernstein is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Naomy Bernstein collaborates with scholars based in Canada and United States. Naomy Bernstein's co-authors include R. F. Pratt, Jeffrey M. Besterman, Arkadii Vaisburg, Daniel Delorme, Rui‐Yang Yang, Stephen Hanessian, Robert J. Maguire, A. Robert MacLeod, Stephen Claridge and Nadine H. Elowe and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Naomy Bernstein

7 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomy Bernstein Canada 7 180 88 31 15 13 7 232
Pranavanand Nyshadham United States 9 189 1.1× 85 1.0× 26 0.8× 12 0.8× 12 0.9× 11 262
Christian Perez United States 6 143 0.8× 54 0.6× 64 2.1× 4 0.3× 16 1.2× 8 221
Stéphane Ciblat France 10 104 0.6× 193 2.2× 48 1.5× 9 0.6× 16 1.2× 18 294
Prakruti Trivedi India 12 208 1.2× 175 2.0× 71 2.3× 5 0.3× 23 1.8× 14 345
David R. Lancia United States 6 228 1.3× 68 0.8× 30 1.0× 4 0.3× 12 0.9× 6 267
Zhigen Hu United States 7 131 0.7× 107 1.2× 40 1.3× 6 0.4× 16 1.2× 9 222
Jeffrey K. Holden United States 10 146 0.8× 41 0.5× 15 0.5× 5 0.3× 12 0.9× 12 285
Laura C. Meurer United States 11 144 0.8× 175 2.0× 27 0.9× 7 0.5× 39 3.0× 15 334
Samuel Reyes United States 9 121 0.7× 148 1.7× 9 0.3× 11 0.7× 10 0.8× 10 229
Jamie Jarusiewicz United States 10 174 1.0× 105 1.2× 51 1.6× 5 0.3× 7 0.5× 17 300

Countries citing papers authored by Naomy Bernstein

Since Specialization
Citations

This map shows the geographic impact of Naomy Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomy Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomy Bernstein more than expected).

Fields of papers citing papers by Naomy Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomy Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomy Bernstein. The network helps show where Naomy Bernstein may publish in the future.

Co-authorship network of co-authors of Naomy Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Naomy Bernstein. A scholar is included among the top collaborators of Naomy Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomy Bernstein. Naomy Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Claridge, Stephen, Franck Raeppel, Stéphane Raeppel, et al.. (2009). N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 19(24). 6836–6839. 24 indexed citations
2.
Llewellyn, David B., Naomy Bernstein, Stephen Claridge, et al.. (2009). SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorganic & Medicinal Chemistry Letters. 19(10). 2747–2751. 35 indexed citations
3.
Llewellyn, David B., Stephen Claridge, Naomy Bernstein, et al.. (2009). Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(10). 2742–2746. 44 indexed citations
4.
Vaisburg, Arkadii, Naomy Bernstein, Sylvie Fréchette, et al.. (2003). (2-Amino-phenyl)-amides of ω-substituted alkanoic acids as new histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 283–287. 21 indexed citations
5.
Woo, Soon Hyung, Sylvie Fréchette, Giliane Bouchain, et al.. (2002). Structurally Simple Trichostatin A-Like Straight Chain Hydroxamates as Potent Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry. 45(13). 2877–2885. 53 indexed citations
6.
Hanessian, Stephen, Naomy Bernstein, Rui‐Yang Yang, & Robert J. Maguire. (1999). Asymmetric synthesis of L-azetidine-2-carboxylic acid and 3-substituted congeners—conformationally constrained analogs of phenylalanine, naphthylalanine, and leucine. Bioorganic & Medicinal Chemistry Letters. 9(10). 1437–1442. 32 indexed citations
7.
Bernstein, Naomy & R. F. Pratt. (1999). On the Importance of a Methyl Group in β-Lactamase Evolution:  Free Energy Profiles and Molecular Modeling. Biochemistry. 38(32). 10499–10510. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026